Skip to main navigation
Skip to search
Skip to main content
The Hebrew University of Jerusalem Home
Approve / Request updates on publications
Link opens in a new tab
Search content at The Hebrew University of Jerusalem
Home
Profiles
Research units
Research output
Prizes
mTORC1 syndrome (TorS): unifying paradigm for PASC, ME/CFS and PAIS
Jacob Bar-Tana
*
*
Corresponding author for this work
Braun School of Public Health and Community Medicine
Research output
:
Contribution to journal
›
Review article
›
peer-review
4
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'mTORC1 syndrome (TorS): unifying paradigm for PASC, ME/CFS and PAIS'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Mammalian Target of Rapamycin (mTOR)
100%
Encephalomyelitis
100%
Chronic Fatigue Syndrome
100%
Post-acute
100%
Myalgia
100%
Post-acute Infection Syndromes
100%
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
100%
Vulnerability
50%
Neurodegeneration
25%
Metabolic Syndrome
25%
Treatment Options
25%
Disease Entity
25%
Infectious Diseases
25%
Risk Factors
25%
Chronic Phase
25%
Hyperactivity
25%
Chronic Obstructive Pulmonary Disease
25%
Neurocognitive
25%
Non-alcoholic Fatty Liver Disease (NAFLD)
25%
Intermittent Pain
25%
Tana
25%
Psychiatric Dysfunction
25%
Postural Orthostatic Tachycardia Syndrome
25%
Post-exertional Malaise
25%
Unmet
25%
Therapeutic Needs
25%
Medicine and Dentistry
Infection
100%
Pathophysiology
100%
Mechanistic Target of Rapamycin
100%
Myalgia
100%
Encephalomyelitis
100%
Chronic Fatigue Syndrome
100%
Diseases
66%
Cancer
33%
Metabolic Syndrome
33%
Chronic Obstructive Pulmonary Disease
33%
Neurodegeneration
33%
Nonalcoholic Fatty Liver
33%
Hyperactivation
33%
Malaise
33%
Postural Orthostatic Tachycardia Syndrome
33%
Systemic Juvenile Idiopathic Arthritis
33%
Treatment Option
33%